stockportfolio.pro
Wellgistics Health, Inc. (WGRX)
Healthcare · Pharmaceutical Retailers · NasdaqCM
Wellgistics Health, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $32.78M | $0 | $18.13M | $23.34M |
| Gross profit | $5.75M | — | $1.77M | $-6.43M |
| Net income | $-2.74M | $-2.90M | $-6.86M | $-101.27M |
| Net margin | -8.4% | — | -37.8% | -433.9% |
Source: Wellgistics Health, Inc. SEC filings (10-K).
Explore 4 years of Wellgistics Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track WGRX in your portfolio →
Wellgistics Health, Inc. financial history by metric
About Wellgistics Health, Inc.
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Wellgistics Health, Inc. — frequently asked questions
What is Wellgistics Health, Inc.'s revenue?
Wellgistics Health, Inc. (WGRX) reported revenue of $23.34M for fiscal year 2025, up 28.7% from the prior year, according to its SEC filings.
Is Wellgistics Health, Inc. profitable?
No — WGRX reported a net loss of $-101.27M in fiscal 2025.
What is WGRX's P/E ratio?
Wellgistics Health, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Wellgistics Health, Inc. growing?
WGRX's revenue grew at roughly -10.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Wellgistics Health, Inc. have?
As of fiscal year 2025, WGRX carried roughly $23.67M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Wellgistics Health, Inc.'s gross margin?
WGRX's gross margin was -27.5% in fiscal 2025 — gross profit of $-6.43M on revenue of $23.34M.
What is Wellgistics Health, Inc.'s market cap?
Wellgistics Health, Inc. (WGRX) has a market capitalization of about $9.58M, based on the latest data in our nightly-refreshed cache.
When does Wellgistics Health, Inc.'s fiscal year end?
WGRX's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Wellgistics Health, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.